Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation (Oncotarget (2019) 10 (1874-1886) DOI: 10.18632/oncotarget.26740)

Published

Journal Article

© 2019 Impact Journals LLC. All rights reserved. This article has been corrected: In Figure 2D, the panel for the loading control should be labeled 'tubulin', not 'GAPD.' We have corrected the legend to Figure 2D by updating this sentence: "Phospho-CrkL is a marker for Abl kinase activity while a-tubulin is a loading control." In addition, we have added a sentence to the legend of Figure 5C to clarify the origin of the lysates: "C) Western blot (using the same lysates as Figure 2D) analysis showed no significant difference in total Yap1 protein expression in double treated mice compared to vehicle treated control mice." The corrected Figure 2D and the corrected legend of Figure 5 are shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Duke Authors

Cited Authors

  • Khatri, A; Gu, JJ; McKernan, CM; Xu, X; Pendergast, AM

Published Date

  • October 1, 2019

Published In

Volume / Issue

  • 10 / 57

Start / End Page

  • 6045 - 6046

Electronic International Standard Serial Number (EISSN)

  • 1949-2553

Citation Source

  • Scopus